glp-1 papillary thyroid cancer Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Is it safe to start
Description
Richards, J
Lets talk through this calmly
The data offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy, which could be a major boost for Pfizer after it faced several setbacks in developing obesity drugs
Its results have been modest
Let's tackle them head-on so you can avoid these pitfalls
While these medications had impactful weight loss outcomes, with mean weight reduction in trials ranging from 7 to 10% [3,4,5], they lacked substantial evidence of improvement in cardiovascular outcomes
